The global cell therapy monitoring kits market was valued at USD 1.4 billion in 2025. It is expected to reach USD 1.5 billion in 2026 and is projected to grow to USD 2.5 billion by 2033, registering a 7.6% CAGR from 2026 to 2033. North America accounted for the largest regional share at 40.2% in 2025, while Asia Pacific is expected to record the fastest growth, with a 12.9% CAGR...